Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Hjem Viden Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

Efficacy of the booster dose of SUISENG®: a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis

This work shows the results of one study where the safety and the efficacy of SUISENG® (a vaccine against the Neonatal Piglet Colibacillosis, C. perfringens and C. novyi enterotoxicosis) were assessed. Applying the basic vaccination and the Revaccination to pregnant sows, the efficacy was evaluated by means the serological response, the transfer of maternal immunity and the clinical signs in challenged piglets with two pathogenic strains of E. coli.

Om denne artikel

Forfattere

Liaño, N.; Gibert, X.; Roca, M.; Sitjá, M.

Resume

The results of this study demonstrated the efficacy of SUISENG® after a booster dose against the experimental infection with enterotoxigenic E. coli. The vaccination reduced significantly the clinical signs and the mortality of the piglets suffering from colibacillosis.

Lignende serviceydelser

Lignende produkter

Del